FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014851749> ?p ?o ?g. }

• W2014851749 endingPage "343" @default.
• W2014851749 startingPage "338" @default.
• W2014851749 abstract "This study sought to compare the impact of primary coronary angioplasty and thrombolytic therapy for acute myocardial infarction (AMI) on 1-month infarct size and microvascular perfusion.The effect of the reperfusion strategies of primary coronary angioplasty and thrombolytic therapy on microvascular integrity still remains to be determined.Sixty-two consecutive patients with a first AMI, undergoing intravenous tissue-type plasminogen activator (t-PA) therapy (32 patients, Group I) or primary angioplasty (30 patients, Group II), were studied. Only patients with 1-month Thrombolysis in Myocardial Infarction (TIMI) flow grade 2 or 3 were selected for the study. Patients in whom primary angioplasty was unsuccessful or those with clinical evidence of failed reperfusion were excluded. Microvascular perfusion was assessed at 1 month by intracoronary injection of sonicated microbubbles. Contrast score index (CSI) and wall motion score index (WMSI) were derived using qualitative methods.At baseline there were no significant differences between groups for age, risk factors, time to hospital presentation, Killip class on admission, prevalence of multivessel disease or anterior infarct site, infarct area extension before reperfusion, peak creatine kinase levels and postinfarction treatment. Conversely, significant differences between groups were found at follow-up for percent residual infarct related-artery (IRA) stenosis (70 +/- 12 vs 36 +/- 14 [mean +/- SD], p = 0.0001), CSI (1.02 +/- 0.4 vs. 1.49 +/- 0.5, p = 0.0003) and WMSI (1.67 +/- 0.3 vs. 1.45 +/- 0.3, p = 0.015). In particular, in the subset of patients with TIMI grade 3 flow, a perfusion defect occurred in one or more segments subtended by the IRA in 72% of Group I versus 31% of Group II patients (p < 0.00001) and in 27% of Group I versus 8% of Group II segments (p < 0.00001).The present study shows, in a highly selected cohort with successful IRA recanalization, that primary angioplasty is more effective than thrombolysis in preserving microvascular flow and preventing extension of myocardial damage at 1-month after AMI." @default.
• W2014851749 created "2016-06-24" @default.
• W2014851749 creator A5008079426 @default.
• W2014851749 creator A5019872175 @default.
• W2014851749 creator A5022848650 @default.
• W2014851749 creator A5054336970 @default.
• W2014851749 creator A5059339929 @default.
• W2014851749 creator A5065127092 @default.
• W2014851749 creator A5065764754 @default.
• W2014851749 creator A5090409167 @default.
• W2014851749 date "1998-02-01" @default.
• W2014851749 modified "2023-10-16" @default.
• W2014851749 title "Tissue-Type Plasminogen Activator Therapy Versus Primary Coronary Angioplasty: Impact on Myocardial Tissue Perfusion and Regional Function 1 Month After Uncomplicated Myocardial Infarction" @default.
• W2014851749 cites W1978722924 @default.
• W2014851749 cites W1989257147 @default.
• W2014851749 cites W1997680605 @default.
• W2014851749 cites W1998119841 @default.
• W2014851749 cites W1999553438 @default.
• W2014851749 cites W2000610860 @default.
• W2014851749 cites W2007753802 @default.
• W2014851749 cites W2008582695 @default.
• W2014851749 cites W2016374950 @default.
• W2014851749 cites W2021253052 @default.
• W2014851749 cites W2034177331 @default.
• W2014851749 cites W2039951040 @default.
• W2014851749 cites W2043737958 @default.
• W2014851749 cites W2057438016 @default.
• W2014851749 cites W2059262595 @default.
• W2014851749 cites W2064778528 @default.
• W2014851749 cites W2068663870 @default.
• W2014851749 cites W2073824748 @default.
• W2014851749 cites W2075499032 @default.
• W2014851749 cites W2079075043 @default.
• W2014851749 cites W2082699449 @default.
• W2014851749 cites W2090845248 @default.
• W2014851749 cites W2094066932 @default.
• W2014851749 cites W2116565741 @default.
• W2014851749 cites W2159427299 @default.
• W2014851749 cites W2990123797 @default.
• W2014851749 cites W3025057188 @default.
• W2014851749 cites W4235858444 @default.
• W2014851749 cites W4302828610 @default.
• W2014851749 doi "https://doi.org/10.1016/s0735-1097(97)00487-7" @default.
• W2014851749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9462577" @default.
• W2014851749 hasPublicationYear "1998" @default.
• W2014851749 type Work @default.
• W2014851749 sameAs 2014851749 @default.
• W2014851749 citedByCount "42" @default.
• W2014851749 countsByYear W20148517492012 @default.
• W2014851749 countsByYear W20148517492013 @default.
• W2014851749 countsByYear W20148517492016 @default.
• W2014851749 crossrefType "journal-article" @default.
• W2014851749 hasAuthorship W2014851749A5008079426 @default.
• W2014851749 hasAuthorship W2014851749A5019872175 @default.
• W2014851749 hasAuthorship W2014851749A5022848650 @default.
• W2014851749 hasAuthorship W2014851749A5054336970 @default.
• W2014851749 hasAuthorship W2014851749A5059339929 @default.
• W2014851749 hasAuthorship W2014851749A5065127092 @default.
• W2014851749 hasAuthorship W2014851749A5065764754 @default.
• W2014851749 hasAuthorship W2014851749A5090409167 @default.
• W2014851749 hasConcept C126322002 @default.
• W2014851749 hasConcept C146957229 @default.
• W2014851749 hasConcept C164705383 @default.
• W2014851749 hasConcept C2776045837 @default.
• W2014851749 hasConcept C2776572282 @default.
• W2014851749 hasConcept C2777995511 @default.
• W2014851749 hasConcept C2779581417 @default.
• W2014851749 hasConcept C2780326628 @default.
• W2014851749 hasConcept C2780387585 @default.
• W2014851749 hasConcept C2780400711 @default.
• W2014851749 hasConcept C500558357 @default.
• W2014851749 hasConcept C71924100 @default.
• W2014851749 hasConceptScore W2014851749C126322002 @default.
• W2014851749 hasConceptScore W2014851749C146957229 @default.
• W2014851749 hasConceptScore W2014851749C164705383 @default.
• W2014851749 hasConceptScore W2014851749C2776045837 @default.
• W2014851749 hasConceptScore W2014851749C2776572282 @default.
• W2014851749 hasConceptScore W2014851749C2777995511 @default.
• W2014851749 hasConceptScore W2014851749C2779581417 @default.
• W2014851749 hasConceptScore W2014851749C2780326628 @default.
• W2014851749 hasConceptScore W2014851749C2780387585 @default.
• W2014851749 hasConceptScore W2014851749C2780400711 @default.
• W2014851749 hasConceptScore W2014851749C500558357 @default.
• W2014851749 hasConceptScore W2014851749C71924100 @default.
• W2014851749 hasIssue "2" @default.
• W2014851749 hasLocation W20148517491 @default.
• W2014851749 hasLocation W20148517492 @default.
• W2014851749 hasOpenAccess W2014851749 @default.
• W2014851749 hasPrimaryLocation W20148517491 @default.
• W2014851749 hasRelatedWork W1976644047 @default.
• W2014851749 hasRelatedWork W2005512234 @default.
• W2014851749 hasRelatedWork W2056873483 @default.
• W2014851749 hasRelatedWork W2090944577 @default.
• W2014851749 hasRelatedWork W2121037724 @default.
• W2014851749 hasRelatedWork W2352871888 @default.
• W2014851749 hasRelatedWork W2396906514 @default.
• W2014851749 hasRelatedWork W2397218708 @default.
• W2014851749 hasRelatedWork W2885168853 @default.

• next